(Q37001036)

17 August 2017

Fatigue characteristics in multiple sclerosis: the North American Research Committee on Multiple Sclerosis (NARCOMS) survey (English)

1 reference

17 August 2017

0 references

1

Olympia Hadjimichael

1 reference

17 August 2017

Timothy Vollmer

2

1 reference

17 August 2017

MerriKay Oleen-Burkey

series ordinal

3

1 reference

17 August 2017

North American Research Committee on Multiple Sclerosis

series ordinal

4

1 reference

17 August 2017

14 November 2008

1 reference

Health and Quality of Life Outcomes

17 August 2017

1 reference

17 August 2017

6

1 reference

17 August 2017

100

1 reference

Validation of the NARCOMS registry: diagnosis

17 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Origin of fatigue in multiple sclerosis: review of the literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Fatigue in multiple sclerosis: an example of cytokine mediated sickness behaviour?

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

The effect of immunomodulatory treatment on multiple sclerosis fatigue.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Fatigue associated with multiple sclerosis: diagnosis, impact and management

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Fatigue in multiple sclerosis: definition, pathophysiology and treatment

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Mechanisms of action of interferons and glatiramer acetate in multiple sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Physiopathology and treatment of fatigue in multiple sclerosis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Multiple sclerosis: side effects of interferon beta therapy and their management

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Copolymer 1 induces T cells of the T helper type 2 that crossreact with myelin basic protein and suppress experimental autoimmune encephalomyelitis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Side effect profile of interferon beta-1b in MS: results of an open label trial

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Rating neurologic impairment in multiple sclerosis: An expanded disability status scale (EDSS)

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Fatigue in multiple sclerosis: cross-sectional correlation with brain MRI findings in 71 patients

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

The impact of fatigue on patients with multiple sclerosis.

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Predictors of prescriptions for management of fatigue among veterans with multiple sclerosis

27 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

The relationship between diffuse axonal damage and fatigue in multiple sclerosis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Predictors of alternative medicine use by multiple sclerosis patients

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Fatigue in multiple sclerosis: a comparison of different rating scales and correlation to clinical parameters.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Quality of life in patients with multiple sclerosis: the impact of fatigue and depression.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Disability and treatment patterns of multiple sclerosis patients in United States: a comparison of veterans and nonveterans

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Quality of life in multiple sclerosis: the impact of depression, fatigue and disability.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Mechanisms of action of glatiramer acetate in multiple sclerosis

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Fatigue and declines in cognitive functioning in multiple sclerosis.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Fatigue in multiple sclerosis: relationship to depression, disability, and disease pattern.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Modalities of fatigue in multiple sclerosis: correlation with clinical and biological factors

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Quality of life in multiple sclerosis: measuring the disease effects more broadly.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Reliability and validity of two self-report measures of impairment and disability for MS. North American Research Consortium on Multiple Sclerosis Outcomes Study Group

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Fatigue in MS is associated with specific clinical features.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Measuring the functional impact of fatigue: initial validation of the fatigue impact scale.

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Validation of the NARCOMS Registry: fatigue assessment

4 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Validation of the NARCOMS Registry: pain assessment

4 December 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2596785

Symptomatic medication use in multiple sclerosis

4 December 2018

1 reference

12 December 2020

Symptomatic fatigue in multiple sclerosis

1 reference

12 December 2020

Fatigue in multiple sclerosis compared with chronic fatigue syndrome: A quantitative assessment

1 reference

12 December 2020

Psychosocial correlates of fatigue in multiple sclerosis

1 reference

12 December 2020

A comparison of neuropsychiatric characteristics in chronic fatigue syndrome, multiple sclerosis, and major depression

1 reference

12 December 2020

Clinical aspects of fatigue in multiple sclerosis

1 reference

12 December 2020

Fatigue in Multiple Sclerosis

1 reference

12 December 2020

4-aminopyridine in the treatment of patients with multiple sclerosis. Long-term efficacy and safety

1 reference

12 December 2020

1 reference

12 December 2020

The measurement of fatigue in patients with multiple sclerosis. A multidimensional comparison with patients with chronic fatigue syndrome and healthy subjects

1 reference

12 December 2020

Fatigue in multiple sclerosis and its relationship to depression and neurologic disability

1 reference

12 December 2020

Cognitive and physical fatigue in multiple sclerosis: relations between self-report and objective performance

1 reference

12 December 2020

The Sonya Slifka Longitudinal Multiple Sclerosis Study: methods and sample characteristics

1 reference

12 December 2020

The cost and benefits of employment: a qualitative study of experiences of persons with multiple sclerosis

1 reference

12 December 2020

Clinical response to glatiramer acetate correlates with modulation of IFN-gamma and IL-4 expression in multiple sclerosis

1 reference

12 December 2020

Fatigue therapy in multiple sclerosis: results of a double-blind, randomized, parallel trial of amantadine, pemoline, and placebo

1 reference

12 December 2020

The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus

1 reference

12 December 2020

Disease steps in multiple sclerosis: a simple approach to evaluate disease progression

1 reference

12 December 2020

Identifiers

DOI

10.1186/1477-7525-6-100

1 reference

Dimensions Publication ID

17 August 2017

0 references

1 reference

17 August 2017

PubMed publication ID

19014588

1 reference